Press Releases

 Filter by Provider

Claymont, Delaware--(Newsfile Corp. - February 6, 2026) - JobAssist, an online job application automation platform, has announced the expansion of...

LOWELL, Mass. - Raíces Investment Realty, a new specialized real estate firm serving Lowell and the Merrimack Valley , has officially launched its operations. Founded by local real estate investment property expert Hector Rodriguez , the firm is dedicated to guiding multifamily property owners and investors through complex real estate transitions with a focus on respectful, culturally fluent service.

Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of GSI Technology Inc. (NASDAQ: GSIT) resulting from allegations that GSI Technology may have issued materially misleading business information to the investing public.

St Joseph, MI - With over 50 years of exterior remodeling experience, Dennison Roofing & Gutter Toppers continues to lead the way as a trusted and top-rated roofing contractor in St Joseph. Known for premium workmanship, American-made products, and unmatched warranties, the family-owned business is the go-to source for homeowners seeking durable, energy-efficient roofing solutions and reliable exterior renovations.

OnMed, the leader in tech-enabled hybrid healthcare, has been named Impact Product of the Year by the Impact One Awards — one of the most selective and meaningful recognitions granted to companies making tangible, measurable differences in solving critical societal challenges.

Ogden, UT - Pioneer Overhead Door, based in Ogden, UT, provides a range of services to ensure that garage doors operate smoothly and safely. Whether it's installing a new door, maintaining an existing system, or handling repairs, the company is equipped to manage all aspects of garage door care for both residential and commercial customers.

The law firm of Robbins Geller Rudman & Dowd LLP announces purchasers or acquirers of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) common stock between August 3, 2023 and December 26, 2025, both dates inclusive (the “Class Period”), have until April 6, 2025 to seek appointment as lead plaintiff of the Ultragenyx class action lawsuit. Captioned Bailey v. Ultragenyx Pharmaceutical Inc., No. 26-cv-01097 (N.D. Cal.), the Ultragenyx class action lawsuit charges Ultragenyx and certain of Ultragenyx’s top executives with violations of the Securities Exchange Act of 1934.

East Hanover, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical Research center in San Diego, California, designed to provide world-class scientific infrastructure and drug-discovery capabilities to advance the company’s pipeline for patients.   Once operational in 2029, the approximately 466,000-square-foot facility is expected to house about 1,000 Novartis employees and integrate seamlessly with Novartis global research sites including Cambridge, Massachusetts, and Basel, Switzerland, enabling integrated discovery efforts across regions.  “This new research center will strengthen our scientific leadership and accelerate the discovery of transformative medicines for patients worldwide, while deepening our connectivity with biotech, academic and technology partners across the region,” said Fiona Marshall, President of Biomedical Research at Novartis. “Designed to power future drug discovery, with a focus on genetics and human biology in key therapeutic areas such as neuroscience and oncology, it will create a single Novartis research center within one of the world’s premier life sciences ecosystems—accelerating our pipeline from discovery to patients.”  Government leaders and community partners joined Novartis employees in San Diego to mark the start of construction at the groundbreaking ceremony.  “This investment by Novartis reinforces San Diego as a place where breakthrough science happens and where innovation translates into high-quality jobs and life-changing medicines,” said Todd Gloria, San Diego Mayor. “San Diego is a global leader in life sciences because we bring together world-class talent, cutting-edge research and a collaborative ecosystem that turns discovery into impact. We’re proud to welcome this new research center and to continue building an economy rooted in innovation and results.”  The new facility builds on more than 25 years of Novartis research and development in San Diego and will support end-to-end drug discovery across core disease areas, including neuroscience, global health, oncology and age-related diseases and regenerative medicine. It will also expand the company’s capabilities in next-generation technology platforms, such as gene and cell therapies, RNA-based therapies, biologics and targeted protein degradation, and will advance novel delivery systems that open new therapeutic possibilities.  “Rooted in a strong legacy of innovation in San Diego and California, we are inspired to shape the future—driving new breakthroughs that will transform care for millions of patients worldwide,” said Thierry Diagana, California Sites Head and Global Head of Global Health, Biomedical Research, Novartis.  With advanced artificial intelligence, data and computational capabilities embedded throughout, the facility will be a key part of the global Novartis Biomedical Research network, helping share insights, scale innovation, and deliver meaningful breakthroughs for patients worldwide.  The San Diego research facility is a key pillar of the company’s USD 23 billion US investment. This includes a new flagship manufacturing hub in North Carolina; the opening of a radioligand therapy (RLT) manufacturing facility in Carlsbad, California; investments to expand existing facilities in Indiana and New Jersey; and plans to build new RLT manufacturing facilities in Florida and Texas.  Disclaimer  This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as “potential,” “can,” “will,” “plan,” “may,” “could,” “would,” “expect,” “anticipate,” “look forward,” “believe,” “committed,” “investigational,” “pipeline,” “launch,” or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release; or regarding potential future revenues from such products; or regarding discussions of strategy, plans, expectations or intentions, including discussions regarding our continued investment into new US R&D or manufacturing capabilities. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. Neither can there be any guarantee that the expected benefits from the plans and investments described in this press release will be achieved in the expected timeframe, or at all. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG’s current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.  About Novartis Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 300 million people worldwide.  Reimagine medicine with us: Visit us at https://www.novartis.us and connect with us on LinkedIn US, X/Twitter US and Instagram US.  # # #

New York, NY/ GlobePRWire / Feb 6, 2026 - Collierville, TN — PremierGlow.com, a leading provider of glow-in-the-dark sporting products, is lighting up golf courses and backyards alike with its industry-leading Night Golf range — transforming traditional golf into an unforgettable after-dark experience.

Construction draw management platform recognized for transforming how lenders fund and manage construction loans

Tampa, FL - Helicon continues to address a range of structural and ground-related conditions that affect properties throughout Florida, where soil composition, groundwater movement, and weather patterns play a defining role in long-term stability. Based in Tampa, the company focuses on identifying and addressing the underlying causes of settlement, erosion, and ground movement rather than treating surface symptoms alone.

LONDON, UK / ACCESS Newswire / February 6, 2026 / David Withey's new audiobook, Beware of the Old Bull, brings into the limelight one of the aspects of life we most take for granted: our language. As well as making listeners laugh, Beware of the Old Bull is a satirical comedy about the English language that encourages reflection on the vocabulary we use and inspires a deeper appreciation of it.

This Recognition Highlights Industry-Leading AI Technology That Is Redefining Truckload Planning and Operations

The law firm of Robbins Geller Rudman & Dowd LLP announces purchasers or acquirers of Oracle Corporation (NYSE: ORCL) common stock between June 12, 2025 and December 16, 2025, both dates inclusive (the “Class Period”), to seek appointment as lead plaintiff of the Oracle class action lawsuit. Captioned Barrows v. Oracle Corporation, No. 26-cv-00127 (D. Del.), the Oracle class action lawsuit charges Oracle and certain of Oracle’s top executives with violations of the Securities Exchange Act of 1934.

AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” (Good) of M&C General Insurance Company Limited (M&C General) (St. Lucia). The outlook of these Credit Ratings (ratings) is stable.

Capital to accelerate customer growth, scale embedded lending, and advance AI as a foundational capability

Spencerport, NY - Ranger Roofing Specialists has earned a reputation as a dependable and highly skilled roofing contractor serving Spencerport and the surrounding Rochester suburbs. Family-owned and operated, the company provides top-tier roof repair and roof replacement Spencerport homeowners and businesses can rely on for long-term protection, durability, and peace of mind.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

NEW YORK, NY - February 6, 2026 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT).

LOS ANGELES, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Oracle Corporation (“Oracle” or “the Company”) (NYSE: ORCL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

SAN FRANCISCO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- AtlasFX, a leading SaaS platform for foreign exchange (FX) risk management, today announced that its BankMinder module has been named Treasury Fintech Solution of the Year at the 2026 Trade Treasury Payments Awards. The awards recognize excellence and innovation across trade, treasury, payments and risk technology.

Crawley Removals introduces expanded service packages designed to address the specific challenges of local and long-distance moves across Sussex and Surrey

MILAN, Italy - February 6, 2026 - Courage Production, a Milan-based independent production company, has released its updated "Italy Production Insight". This guide is designed to assist international agencies and production houses in planning shoots that strictly adhere to established sector agreements, avoiding common scheduling pitfalls.

NEW YORK CITY, NEW YORK / ACCESS Newswire / February 6, 2026 / Capital only matters if it changes how a company operates. Otherwise, it's just a figure on a page, impressive in theory and inert in practice.

AM Best has assigned a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of “a” (Excellent) to Southbridge Compañía de Seguros Generales S.A. (Southbridge) (Santiago, Chile). The outlook assigned to these Credit Ratings (ratings) is stable.

Denver, CO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- YES Communities today announced the release of its 2025 Philanthropic Initiative Recap, outlining the impact of its YES We Care programs, which contributed nearly $380,000 in support for residents, team members and communities throughout the year. 

Houston, TX - CX Research Institute announced today the publication of its comprehensive research report evaluating the best signage companies in Houston and the Greater Houston area. Signs by G earned the top ranking with a score of 94 out of 100 points, leading nine other prominent signage providers in a rigorous comparative analysis.

Houston, TX - CX Research Institute announced today the publication of its comprehensive research report evaluating the best foundation repair companies in Houston and the greater Houston metropolitan area. Two Brothers Foundation Repair earned the top ranking with a score of 94 out of 100 points, leading eight other prominent foundation repair providers in a rigorous comparative analysis.

San Diego, CA - CX Research Institute announced today the publication of its comprehensive research report evaluating the best portable storage companies in San Diego, California. Big Box Storage earned the top ranking with a score of 95 out of 100 points, leading eight other prominent portable storage providers in a rigorous comparative analysis.

Harry Davis & Company, a third-generation leader in food and beverage asset advisory and transactional services, today announced the retirement of Rick Rice, who has served as Director of Business Operations since joining the firm in 2023. Rice’s nearly five-decade career in the industry has left an indelible mark on the company, its clients, and the broader food and beverage market.

Institutional money returns to global stock funds for a third straight week, with Europe and emerging markets leading weekly subscriptions as earnings surprises run high and sector rotation favours cyclicals over crowded technology trades.

All Trades Enterprise, Inc. deserves a special mention for those looking for custom kitchen cabinets in Woodland Park and Pueblo, Colorado.

ISI Technology deserves special mention for those looking for CCTV cameras in Vail and Colorado Springs, Colorado.

KBRA releases the January 2026 issue of CMBS Trend Watch.

Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hub Group Inc. (NASDAQ:HUBG) for potential violations of the federal securities laws.

Skinner Transportation Inc. is pleased to announce the appointment of Johnny Cargill as Director of Business Development and Marketing. In this newly created role, Cargill will lead the company's business growth initiatives, marketing strategy and strategic partnerships.

Abitibi Metals Corp. (CSE:AMQ) (OTCQB:AMQFF) has taken a major step forward in establishing itself as a serious emerging copper-gold developer in Québec’s Abitibi Greenstone Belt. The updated estimate shows a 124% increase in total mineral resources since Abitibi optioned the project in 2023, reflecting the results of successive drilling campaigns completed over the past two … Continue reading "Abitibi Metals Delivers 124% Resource Growth at B26, Defining a High-Grade Copper-Gold System of Meaningful Scale"

Drawing on enterprise sales experience in Tampa, Florida, Darius McGrew explains how sales-driven discipline, risk awareness and communication skills translate into effective IT leadership in today’s complex business environments.